Wei Quan

Title: Innovations of Wei Quan in Pharmaceutical Treatments

Introduction

Wei Quan is an accomplished inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of chronic subdural hematoma. His innovative approach combines the use of statins and adrenocortical hormones to enhance therapeutic outcomes.

Latest Patents

Wei Quan holds a patent for the joint application of statin and adrenocortical hormone for treating chronic subdural hematoma. This invention provides a pharmaceutical product that accelerates hematoma absorption and improves the therapeutic effect of single oral administration of a statin-based product. Notably, the dosage of the adrenocortical hormone used in this treatment is only 1/10 of what is typically required in large-dose hormonal therapy.

Career Highlights

Throughout his career, Wei Quan has demonstrated a commitment to advancing medical treatments. His innovative patent reflects his dedication to improving patient care and outcomes in neurology.

Collaborations

Wei Quan has worked alongside notable colleagues, including Jianning Zhang and Rongcai Jiang. Their collaborative efforts have contributed to the development of effective pharmaceutical solutions.

Conclusion

Wei Quan's contributions to the field of pharmaceuticals, particularly through his innovative patent, highlight his role as a significant inventor in medical advancements. His work continues to influence the treatment of chronic subdural hematoma and showcases the potential of combining existing therapies for improved patient outcomes.